These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21688649)

  • 21. Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
    Mohammedi I; Piens MA; Padoin C; Robert D
    Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):358-60. PubMed ID: 15875225
    [No Abstract]   [Full Text] [Related]  

  • 22. Rapid high performance liquid chromatographic assay for determination of voriconazole concentration in human plasma.
    Sangsiriwut K; Chayakulkeeree M
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S98-103. PubMed ID: 23590028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of voriconazole in falcons.
    Schmidt V; Demiraj F; Di Somma A; Bailey T; Ungemach FR; Krautwald-Junghanns ME
    Vet Rec; 2007 Aug; 161(8):265-8. PubMed ID: 17720963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole.
    Porte L; Khatibi S; Hajj LE; Cassaing S; Berry A; Massip P; Linas MD; Magnaval JF; Sans N; Marchou B
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):891-4. PubMed ID: 16714039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
    Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
    Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracavitary voriconazole for the treatment of hemoptysis complicating Pseudallescheria angusta pulmonary mycetomas in fibrocystic sarcoidosis.
    Kravitz JN; Steed LL; Judson MA
    Med Mycol; 2011 Feb; 49(2):198-201. PubMed ID: 20831365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole.
    Matsumoto Y; Oh-I T; Nagai A; Ohyama F; Ooishi T; Tsuboi R
    J Dermatol; 2009 Feb; 36(2):98-102. PubMed ID: 19284454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen.
    Capitano B; Potoski BA; Husain S; Zhang S; Paterson DL; Studer SM; McCurry KR; Venkataramanan R
    Antimicrob Agents Chemother; 2006 May; 50(5):1878-80. PubMed ID: 16641467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nebulized voriconazole in infections with Scedosporium apiospermum--case report and review of the literature.
    Holle J; Leichsenring M; Meissner PE
    J Cyst Fibros; 2014 Jul; 13(4):400-2. PubMed ID: 24263169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
    Shima H; Miharu M; Osumi T; Takahashi T; Shimada H
    Pediatr Blood Cancer; 2010 Jul; 54(7):1050-2. PubMed ID: 20146339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinician ordering practices for voriconazole therapeutic drug monitoring: experiences of a referral laboratory.
    Miyakis S; van Hal SJ; Solvag CJ; Ray J; Marriott D
    Ther Drug Monit; 2010 Oct; 32(5):661-4. PubMed ID: 20720520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature.
    Rahman FU; Irfan M; Fasih N; Jabeen K; Sharif H
    Infection; 2016 Feb; 44(1):127-32. PubMed ID: 26353885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C
    J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
    Davis JL; Salmon JH; Papich MG
    Am J Vet Res; 2006 Jun; 67(6):1070-5. PubMed ID: 16740104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Voriconazole in fungal keratitis caused by Scedosporium apiospermum.
    Hernández Prats C; Llinares Tello F; Burgos San José A; Selva Otaolaurruchi J; Ordovás Baines JP
    Ann Pharmacother; 2004 Mar; 38(3):414-7. PubMed ID: 14755065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose voriconazole in a critically ill pediatric patient with neuroblastoma.
    Alffenaar JW; Doedens RA; Groninger E; Kosterink JG
    Pediatr Infect Dis J; 2008 Feb; 27(2):189-90. PubMed ID: 18174859
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pulmonary non invasive infection by Scedosporium apiospermum].
    Cruz R; Barros M; Reyes M
    Rev Chilena Infectol; 2015 Aug; 32(4):472-5. PubMed ID: 26436797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
    Trifilio S; Ortiz R; Pennick G; Verma A; Pi J; Stosor V; Zembower T; Mehta J
    Bone Marrow Transplant; 2005 Mar; 35(5):509-13. PubMed ID: 15654347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
    Lutsar I; Roffey S; Troke P
    Clin Infect Dis; 2003 Sep; 37(5):728-32. PubMed ID: 12942409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic drug monitoring of voriconazole in children.
    Chen J; Chan C; Colantonio D; Seto W
    Ther Drug Monit; 2012 Feb; 34(1):77-84. PubMed ID: 22210097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.